Current pain and headache reports · 2026
Radiopharmaceuticals for the Treatment of Chronic Cancer Pain.
СтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Anwar Ahmed I, Nytes Gwendolyn M, Shiferaw Barnabas T, Shekoohi Sahar, Abd-Elsayed Alaa, Kaye Alan D
Аннотация
PURPOSE OF REVIEW: Cancer-induced bone pain is a frequent, debilitating complication seen in metastatic cancers and often poorly controlled with conventional analgesics. Radiopharmaceutical therapy offers a targeted pain relief with beta emitters providing sustained analgesia and alpha emitters offering potent cytotoxicity and survival benefits.
RECENT FINDINGS: Emerging agents such as Lu-EDTMP show promising pain palliation with manageable toxicity. Radiopharmaceutical therapy enables systemic treatment of bone metastases and reduces opioid dependence while complementing local therapies. This review aims to summarize the mechanisms, clinical evidence, advantages, limitations, and future directions of radiopharmaceutical therapy in the management of cancer-induced bone pain.
RECENT FINDINGS: Emerging agents such as Lu-EDTMP show promising pain palliation with manageable toxicity. Radiopharmaceutical therapy enables systemic treatment of bone metastases and reduces opioid dependence while complementing local therapies. This review aims to summarize the mechanisms, clinical evidence, advantages, limitations, and future directions of radiopharmaceutical therapy in the management of cancer-induced bone pain.